Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Presented at the American Society of Hematology Annual Meeting, the award and lectureship recognises individuals from outside the United States who have made significant contributions to Haematology.

Emeritus Professor Irene Roberts holds the 2022 Ham-Wasserman Lecture Award from the American Society of Hematology.

Emeritus Professor Irene Roberts, leader of the Fetal and Neonatal Haematology Group at the MRC Molecular Haematology Unit delivered the prestigious 2022 Ham-Wasserman Lecture at the 64th ASH Annual Meeting and Exposition, held in New Orleans Louisiana in December 2022. The Ham-Wasserman lecture honours two past ASH presidents, Dr Thomas Hale Ham and Dr Louis R Wasserman.

Professor Roberts delivered the lecture entitled: ‘Why Is the Risk of Developing Leukemia So High in Children with Down Syndrome and What Can We Do About It?’

The American Society of Hematology Annual Meeting is a high-profile event in the field of hematology, with past meetings attracting more than 30,000 attendees.

The lecture abstract is now available on the ASH website: 2022 Ham-Wasserman Lecture

Similar stories

Oxford gets £122m funding for healthcare research

Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients. The funding was awarded to the two NIHR Biomedical Research Centres.

Study raises hope of pre-school type 1 diabetes screening programme

Researchers in Oxford have launched the first UK study in the general population to test for early markers of type 1 diabetes before children develop symptoms or need insulin.

Oxford scientist named Australian of the Year in the UK

The Oxford Vaccine Group’s Lead Statistician, Professor Merryn Voysey, received the prestigious Australian of the Year in the UK award at a gala dinner recently.

New model for infant leukaemia announced

The breakthrough could lead to development of new treatments for infant Acute Lymphoblastic Leukaemia.

Why it's so hard to treat pain in infants

For decades physicians believed that premature babies didn’t experience pain. Here’s what doctors know now – and the innovative solutions being embraced by today's caregivers.

New atlas revealed of bone marrow haematopoiesis during development

A new study published this week in Nature, provides the most detailed analysis so far of the prenatal development of blood and immune cells in the bone marrow.